• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,935.00(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zenotech Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Sun Pharma
  • BSE Code : 7341.0
  • ISIN : INE486F01012
58.01 -1 (-1.71%)
  • As on 26 Apr 2025 (EOD)

  • Today’s Low

    56.40

  • Today’s High

    59.98

  • Open

    58.80

  • Perv Close

    59.02

  • 52W Low

    51.00

  • 52W High

    107.79

Key Indicators

  • P/E(TTM)

    90.64

  • Mar.Cap (₹Cr.)

    354.04

  • Div & Yield %

    0.00

  • Book Value(₹)

    15.27

  • Debt-Equity Ratio

    -1.71

  • AGM Date

    25-Apr-2025

  • EPS

    0.64

  • P/E Ratio

    90.64

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    354.04

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    61.03

  • BV (₹)

    15.30

  • Sales( ₹ in Cr.)

    40.83

  • NP (in Cr.)

    8.33

  • NP Var(%)

    -28.0

  • Div%

    0.0

  • CPS (₹)

    2.50

  • EPS (₹)

    1.40

  • Traded Value (₹ in Lakhs)

    354.04

  • 52 Week High

    107.79

  • 52 Week Low

    51.00

  • Price BSE

    58.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    354.04

  • P/C Ratio

    23.00

  • P/E Ratio

    42.50

  • Price Vs.BV

    1.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 40.83 42.42 36.57 22.45 26.02 13.03
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 40.83 42.42 36.57 22.45 26.02 13.03
Other Income 1.00 1.08 0.63 0.41 7.54 4.71
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 -0.01
Total Income 41.83 43.50 37.20 22.86 33.56 17.73
EXPENDITURE :            
Raw Materials 0.00 0.06 0.00 0.03 0.50 0.71
Power and Fuel Cost 2.69 3.79 3.25 3.12 3.29 3.68
Employee Cost 9.46 7.88 7.10 6.49 5.76 4.98
Other Manufacturing Expenses 8.70 7.67 6.66 4.67 5.61 4.64
Selling and Administration Expenses 2.33 2.00 1.91 1.62 1.75 2.21
Miscellaneous Expenses 0.43 0.31 0.19 0.13 0.12 0.32
Employee Benefit Expenses 9.46 7.88 7.10 6.49 5.76 4.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 23.61 21.72 19.10 16.06 17.04 16.54
Operating Profit 18.23 21.79 18.09 6.79 16.52 1.20
Interest 0.00 0.11 1.22 1.55 0.89 0.12
Gross Profit 18.23 21.68 16.87 5.24 15.63 1.08
Depreciation 7.09 7.17 6.97 6.46 4.85 4.20
Profit Before Tax 11.14 14.51 9.90 -1.22 10.78 -3.12
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.84 2.92 -12.27 0.00 0.00 0.00
Reported Net Profit 8.30 11.59 22.18 -1.22 10.78 -3.13
Extraordinary Items -0.03 0.03 0.00 0.00 6.37 0.00
Adjusted Net Profit 8.33 11.56 22.18 -1.22 4.41 -3.13
Adjustment below Net Profit -0.03 0.04 0.06 -0.01 -0.05 0.01
P & L Balance brought forward -188.30 -199.93 -222.17 -220.94 -231.68 -228.56
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -180.03 -188.30 -199.93 -222.17 -220.94 -231.68
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.36 1.90 3.63 -0.20 1.77 0.00
Earnings Per Share(Adj)-Unit Curr 1.36 1.90 3.63 -0.20 1.77 0.00
Book Value 14.84 13.48 11.57 7.93 8.13 6.37
Book Value(Adj)-Unit Curr 14.84 13.48 11.57 7.93 8.13 6.37

Shareholding Pattern

  • Promoter Group

    68.84%

  • Public Share Holding

    31.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 42,014,578 68.84 42,014,578 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 42,014,578 68.84 42,014,578 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 600,000 0.98 600,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,364 0.01 4,364 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 604,364 0.99 604,364 2
2] Non Institution
Bodies Corporate 2,652,418 4.35 2,652,418 61
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 211,795 0.35 204,327 113
Foreign Non Institution Other 692,791 1.14 0 1
Hindu Undivided Families 951,892 1.56 951,892 279
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 9,122,748 14.95 4,029,510 54
Individuals holding nominal share capital up to Rs. 1 lakh 4,779,881 7.83 4,737,889 10,178
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 101 0.00 100 1
Sub Total 18,411,626 30.17 12,576,136 10,687
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,030,568 100.00 55,195,078 10,690

Company Background

Zenotech Laboratories LtdPharmaceuticals - Indian - Formulations

  • Zenotech Laboratories Ltd
  • BSE Code : 7341.0
  • ISIN : INE486F01012

  • Incorporation Year

    1989

  • Registered Office

    S No 250-252 Turkapally Villag
    Shameerpet Mandal RR District, Hyderabad,
    Telangana-500078

  • Telephone

    91-40-23480430/0435

  • FAX

    91-40-23480429

  • Chairman

    Azadar Hussain Khan

  • Managing Director

  • Company Secretary

    Abdul Gafoor Mohammad

  • Auditor

    PKF Sridhar & Santhanam LLP

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Zenotech Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zenotech Lab. 58.01 41.84 40.83 70.74 4.09
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92